2023 - Research.com Medicine in United States Leader Award
2023 - Research.com Genetics in United States Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Genetics and Molecular Biology in United States Leader Award
2021 - Japan Prize for their pioneering work in conceptualizing a multi-step model of carcinogenesis and its application and impact on improving cancer diagnosis and therapy.
2020 - Jessie Stevenson Kovalenko Medal, US National Academy of Sciences For his pioneering work in elucidating the fundamental principles of the molecular basis of human cancer and the application of this knowledge to improve the clinical management of patients.
2019 - Albany Medical Center Prize in Medicine and Biomedical Research
2019 - Gruber Prize in Genetics
2015 - Fellow, National Academy of Inventors
2015 - Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson for his breakthroughs in oncology research.
2013 - Breakthrough Prize in Life Sciences for cancer genomics and tumor suppressor genes.
2007 - Robert J. and Claire Pasarow Foundation Medical Research Award
2006 - Fellow of the American Association for the Advancement of Science (AAAS)
2001 - Member of the National Academy of Medicine (NAM)
2000 - Charles S. Mott Prize, General Motors Cancer Research Foundation
1998 - Paul Ehrlich and Ludwig Darmstaedter Prize
1998 - William Allan Award, the American Society of Human Genetics
1998 - Louisa Gross Horwitz Prize, Columbia University
1997 - William Beaumont Prize, American Gastroenterological Association (AGA)
1992 - Fellow of the American Academy of Arts and Sciences
1992 - Member of the National Academy of Sciences
1992 - Canada Gairdner International Award
Member of the Association of American Physicians
Genetics, Cancer research, Gene, Mutation and Carcinogenesis are his primary areas of study. His Genetics study frequently links to other fields, such as Cell biology. The concepts of his Cancer research study are interwoven with issues in Immunology, Point mutation, Tumor suppressor gene and Colorectal cancer, Adenomatous polyposis coli.
Gene and Molecular biology are frequently intertwined in his study. His Mutation research includes elements of Phenotype, Malignancy and Cell growth. His Carcinogenesis study combines topics from a wide range of disciplines, such as Tumor progression, KRAS and Carcinoma.
His primary areas of study are Gene, Cancer research, Genetics, Molecular biology and Cancer. Gene is frequently linked to DNA in his study. While the research belongs to areas of Cancer research, Bert Vogelstein spends his time largely on the problem of Colorectal cancer, intersecting his research to questions surrounding Oncology.
His Genetics and Mutation, Allele, DNA mismatch repair, Genome and Chromosome investigations all form part of his Genetics research activities. His study looks at the intersection of Molecular biology and topics like Cell biology with Cell cycle. His study in Cancer focuses on Pancreatic cancer in particular.
Bert Vogelstein spends much of his time researching Cancer, Cancer research, Internal medicine, Pathology and Oncology. The various areas that he examines in his Cancer study include Aneuploidy, Computational biology and Stem cell. The Cancer research study combines topics in areas such as Gene, Somatic cell, Blockade, Gene mutation and KRAS.
His Gene study is associated with Genetics. His Pathology research integrates issues from Biomarker, Carcinogenesis and Bladder cancer. His work in the fields of Oncology, such as Adjuvant, intersects with other areas such as In patient.
Bert Vogelstein mostly deals with Cancer research, Cancer, Internal medicine, Mutation and Pathology. His Cancer research study incorporates themes from Gene expression profiling, Carcinogenesis, Somatic cell, Gene mutation and Loss of heterozygosity. His Cancer research is multidisciplinary, incorporating elements of Aneuploidy, Gold standard, Melanoma, Lung and Genetic heterogeneity.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology. His Mutation study deals with the bigger picture of Genetics. Bert Vogelstein interconnects Biomarker, KRAS, GNAS complex locus and Glioma in the investigation of issues within Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Andrew P. Feinberg;Bert Vogelstein.
Analytical Biochemistry (1983)
A genetic model for colorectal tumorigenesis
Eric R. Fearon;Bert Vogelstein.
Cell (1990)
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El-Deiry;Takashi Tokino;Victor E. Velculescu;Daniel B. Levy.
Cell (1993)
p53 mutations in human cancers
Monica Hollstein;David Sidransky;Bert Vogelstein;Curtis C. Harris.
Science (1991)
Genetic alterations during colorectal-tumor development.
Bert Vogelstein;Eric R. Fearon;Stanley R. Hamilton;Scott E. Kern.
The New England Journal of Medicine (1988)
Surfing the p53 network
Bert Vogelstein;David Lane;Arnold J. Levine.
Nature (2000)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett.
The New England Journal of Medicine (2015)
Cancer Genome Landscapes
Bert Vogelstein;Nickolas Papadopoulos;Victor E. Velculescu;Shibin Zhou.
Science (2013)
Lessons from Hereditary Colorectal Cancer
Kenneth W Kinzler;Bert Vogelstein;Bert Vogelstein.
Cell (1996)
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin.
Science (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University
Johns Hopkins University School of Medicine
Johns Hopkins University School of Medicine
Memorial Sloan Kettering Cancer Center
Johns Hopkins University School of Medicine
The University of Texas MD Anderson Cancer Center
Johns Hopkins University
Case Western Reserve University
Duke University
The University of Texas at Dallas
Spanish National Research Council
ETH Zurich
St. Jude Children's Research Hospital
Queen's University Belfast
Yale University
PSL University
King Abdullah University of Science and Technology
Université Paris Cité
Northwestern University
Case Western Reserve University
Temple University
Georgia State University
Columbia University
University of Michigan–Ann Arbor
Rutgers, The State University of New Jersey
Imperial College London